ClinicalTrials.gg
RecruitingNCT07795580Updated Aug 31, 2026

The Effects of Low-Intensity Endurance Exercise on Improving Fatigue, Sleep, Quality of Life, Mitochondrial Function, Cellular Bioelectrical Impedance Phase Angle, and Predictors of Exercise Adherence in Patients With Lung Cancer

An interventional study of Low-Intensity Continuous Endurance Exercise Training and Low-Intensity Interval Endurance Exercise Training in Lung Cancer (Diagnosis), sponsored by Taipei Medical University. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

To conduct a randomized controlled trial (RCT) targeting lung cancer patients with cancer-related fatigue to achieve the following objectives:

Objective 1: To investigate whether a low-intensity endurance exercise intervention can effectively improve mitochondrial DNA content, mitochondrial function, mitochondrial oxidative phosphorylation complex enzyme concentrations, cellular bioelectrical impedance phase angle, cancer-related fatigue, and quality of life in lung cancer patients with cancer-related fatigue.

Objective 2: To explore whether the low-intensity endurance exercise intervention improves cancer-related fatigue and quality of life in lung cancer patients through direct or indirect effects by modulating mitochondrial DNA content, mitochondrial function, mitochondrial oxidative phosphorylation complex enzyme concentrations, and cellular bioelectrical impedance phase angle.

Objective 3: To investigate the correlation between personality traits and adherence to low-intensity endurance exercise in lung cancer patients.

Objective 4: To investigate whether a low-intensity endurance exercise intervention can effectively improve sleep quality in lung cancer patients with cancer-related fatigue.

Objective 5: To investigate whether a low-intensity endurance exercise intervention can effectively reduce stress in lung cancer patients with cancer-related fatigue.

Read the detailed description

After enrollment, participants will be randomly assigned to one of the following three groups:

  1. Control Group Participants assigned to the control group will not receive any exercise intervention and will be instructed to maintain their usual daily lifestyle and physical activity throughout the study period.
  2. Low-Intensity Continuous Endurance Exercise Training Group (Level 2) Participants will perform Level 2 low-intensity continuous endurance exercise for at least 30 consecutive minutes per day, 5 days per week. Exercise intensity will be maintained at 75-80% of peak heart rate (HRpeak), corresponding to a Rating of Perceived Exertion (RPE) of 11-12 (light). At this intensity, participants should perceive the exercise as relatively easy, with an increased breathing rate but still be able to carry on a conversation comfortably, although occasional pauses for breathing may be required.

    Each exercise session will consist of:

    • a 5-minute warm-up,
    • 30 minutes of continuous low-intensity endurance exercise, and
    • a 10-minute cool-down, during which exercise intensity will be gradually reduced until cessation.
  3. Low-Intensity Interval Endurance Exercise Training Group

Participants will perform 30 minutes of interval endurance exercise per day, 5 days per week. Each session will consist of five alternating cycles, with each cycle including:

  • 3 minutes of Level 2 low-intensity endurance exercise at 75-80% HRpeak (RPE 11-12), followed by
  • 3 minutes of Level 1 very low-intensity endurance exercise at 65-75% HRpeak, corresponding to an RPE \<11 (very light), during which participants should perceive the exercise as very easy.

Each exercise session will begin with a 5-minute warm-up and conclude with a 10-minute cool-down, during which exercise intensity will be gradually reduced until exercise cessation.

02

Conditions studied

  • Lung Cancer (Diagnosis)

Keywords

  • Low-Intensity Endurance Exercise
  • Cancer-Related Fatigue (CRF)
03

In context

Lung Neoplasms

5,422 studies on the registry are indexed under Lung Neoplasms; 1,346 are open to participants now.

This study's planned enrollment of 450 is above the median of 60 across 3,656 interventional studies indexed under Lung Neoplasms.

Browse Lung Neoplasms studies →

Lead sponsor

Taipei Medical University is the lead sponsor of 257 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Individuals diagnosed with lung cancer by a physician.
  2. Aged 20 years or older.
  3. Education level of elementary school graduation or above.

Exclusion criteria

Exclusion Criteria:

  1. Individuals who are unable to communicate in Mandarin Chinese, Taiwanese, or Hakka.
  2. Individuals whose physical condition is determined by a physician to be unsuitable for performing any exercise.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
450 participants (estimated)

Study arms

  • No intervention
    Control Group

    Participants assigned to the control group will not receive any exercise intervention and will be instructed to maintain their usual daily lifestyle and physical activity throughout the study period.

  • Experimental
    continuous exercise group

    Participants will perform Level 2 low-intensity continuous endurance exercise for at least 30 consecutive minutes per day, 5 days per week. Exercise intensity will be maintained at 75-80% of peak heart rate (HRpeak), corresponding to a Rating of Perceived Exertion (RPE) of 11-12 (light). Each exercise session will consist of a 5-minute warm-up, 30 minutes of continuous low-intensity endurance exercise, and a 10-minute cool-down.

    Behavioral: Low-Intensity Continuous Endurance Exercise Training

  • Experimental
    low-intensity exercise group

    Participants will perform 30 minutes of interval endurance exercise per day, 5 days per week. Each session will consist of five alternating cycles, with each cycle including 3 minutes of Level 2 low-intensity endurance exercise at 75-80% HRpeak (RPE 11-12), followed by 3 minutes of Level 1 very low-intensity endurance exercise at 65-75% HRpeak (RPE \<11). Each exercise session will begin with a 5-minute warm-up and conclude with a 10-minute cool-down.

    Behavioral: Low-Intensity Interval Endurance Exercise Training

Interventions

  • BehavioralLow-Intensity Continuous Endurance Exercise Training

    Participants will perform Level 2 low-intensity continuous endurance exercise for at least 30 consecutive minutes per day, 5 days per week. Intensity at 75-80% HRpeak (RPE 11-12).

  • BehavioralLow-Intensity Interval Endurance Exercise Training

    Participants will perform 30 minutes of interval endurance exercise per day, 5 days per week. Five alternating cycles (3 mins Level 2 at 75-80% HRpeak + 3 mins Level 1 at 65-75% HRpeak).

06

What researchers measure

Primary outcomes

  1. Change from baseline in Cancer-Related Fatigue (CRF)

    Evaluated by the Brief Fatigue Inventory-Taiwan (BFI-T) and the ICD-10 diagnostic criteria for cancer-related fatigue. The BFI-T total score ranges from 0 to 90, with higher scores indicating greater fatigue severity and interference with daily life.

    Time frame: Baseline, Week 6, Week 12, and monthly up to 15 months.

  2. Change from baseline in leukocyte mitochondrial DNA copy number and mitochondrial function

    Leukocyte mitochondrial DNA (mtDNA) copy number will be quantified using real-time quantitative PCR (qPCR) by calculating the relative mtDNA-to-nuclear DNA ratio. Mitochondrial function will be evaluated by measuring the oxygen consumption rate (OCR) and ATP coupling efficiency using the Seahorse XFp extracellular flux analyzer.

    Time frame: Baseline, Week 6, Week 12, and monthly up to 15 months.

  3. Change from Baseline in Cellular Bioelectrical Impedance Phase Angle and Skeletal Muscle Mass

    Measured by the InBody S10 multi-frequency bioelectrical impedance analyzer. Higher phase angle values indicate better cellular integrity and cell function.

    Time frame: Baseline, Week 6, Week 12, and monthly up to 15 months.

  4. Change from Baseline in Quality of Life (QoL)

    Evaluated using the Functional Assessment of Cancer Therapy-General (FACT-G) Taiwan version. The total score ranges from 0 to 108, with higher scores representing better health-related quality of life.

    Time frame: Baseline, Week 6, Week 12, and monthly up to 15 months.

Secondary outcomes

  1. Change from Baseline in Sleep Quality

    Assessed by the Pittsburgh Sleep Quality Index (PSQI) Taiwan form. Total scores range from 0 to 21, where a score \> 5 indicates poor sleep quality.

    Time frame: Baseline, Week 6, Week 12, and monthly up to 15 months.

  2. Change from Baseline in Perceived Stress

    Measured by the 10-item Perceived Stress Scale (PSS-10). Total scores range from 0 to 40, with higher scores indicating higher levels of perceived stress.

    Time frame: Baseline, Week 6, Week 12, and monthly up to 15 months.

  3. Predictors of Exercise Adherence (Personality Traits)

    Evaluated using the International English Big-Five Mini-Markers (Chinese version) at baseline to explore its correlation with the 12-week low-intensity endurance exercise adherence rate.

    Time frame: Baseline, Week 6, Week 12, and monthly up to 15 months.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07795580
Responsible party
Sponsor
First posted
Aug 31, 2026
Start date
Jul 1, 2026
Primary completion
Jul 2028 (estimated)
Completion
Jul 2029 (estimated)
Last update
Aug 31, 2026

Study contacts

Hsiu Ting Tsai, PhD
Contact
hsiuting@tmu.edu.tw
886227361661 ext. 6330
Hsin Hui Huang, Master's degree
Contact
d432113014@tmu.edu.tw
886227361661 ext. 6330

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion